An improved method to remove the 2-nitrophenylsulfenyl protecting group in the conventional radiosynthesis of the PET radiotracer [C-11]d-threo-methylphenidate was developed. The method uses the nonvolatile reagents sulfuric acid and l-cysteine. In addition it was demonstrated that solid phase extra
A rapid one-step radiosynthesis of [11C]-d-threo-methylphenidate
✍ Scribed by Matthew D. Moran; Alan A. Wilson; Winston T. Stableford; Min Wong; Armando Garcia; Sylvain Houle; Neil Vasdev
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- French
- Weight
- 174 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Carbon‐11 labelled d‐threo‐methylphenidate ([^11^C]‐(1)), a radiopharmaceutical commonly used to image the dopamine transporter, has been labelled in one step using [^11^C]‐methyl triflate. No protection of the nitrogen atom on the piperidine ring of d‐threo‐ritalinic acid·HCl was required, as O‐methylation was favored over N‐methylation by performing the methylation in buffered solutions which effectively protonate and protect the amine functionality. The reaction was effectively carried out at room temperature in solution by captive solvent ‘LOOP’ methods or using conventional glass vials. Copyright © 2010 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract (__R__)‐(−)‐2‐[^11^C]Methoxy‐__N__‐__n__‐propylnorapomorphine ([^11^C]MNPA ([^11^C]2)) is an agonist radioligand of interest for imaging D~2~/D~3~ receptors __in vivo__. Here we sought to develop an improved radiosynthesis of this radioligand. Reference 2 was synthesized in nine steps w
## Abstract The promising __β__‐amyloid PET imaging agent, [^11^C]‐6‐OH‐BTA‐1, has been radiolabelled in one step using [^11^C]‐methyl triflate. No protection of the 6‐hydroxy group is required, greatly simplifying the synthetic method. The reaction may be carried out in solution or by the captive
## Abstract Within a novel series of 2‐oxazolidinones developed in the past by Sanofi‐Synthélabo, SL25.1188 ((__S__)‐5‐methoxymethyl‐3‐[6‐(4,4,4‐trifluorobutoxy)benzo[__d__]isoxazol‐3‐yl]oxazolidin‐2‐one), a compound that inhibits selectively and competitively MAO‐B in human and rat brain (Ki value